HomeCompareDMPHF vs SPHD

DMPHF vs SPHD: Dividend Comparison 2026

DMPHF yields 2.17% · SPHD yields 4.33%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 DMPHF wins by $221.00 in total portfolio value· pulled ahead in Year 10
10 years
DMPHF
DMPHF
● Live price
2.17%
Share price
$48.60
Annual div
$1.05
5Y div CAGR
14%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$26.8K
Annual income
$1,051.08
Full DMPHF calculator →
SPHD
SPHD
● Live price
4.33%
Share price
$49.34
Annual div
$2.14
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$26.5K
Annual income
$571.32
Full SPHD calculator →

Portfolio growth — DMPHF vs SPHD

📍 DMPHF pulled ahead of the other in Year 10

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodDMPHFSPHD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, DMPHF + SPHD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
DMPHF pays
SPHD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

DMPHF
Annual income on $10K today (after 15% tax)
$184.42/yr
After 10yr DRIP, annual income (after tax)
$893.42/yr
SPHD
Annual income on $10K today (after 15% tax)
$367.92/yr
After 10yr DRIP, annual income (after tax)
$485.62/yr
At 15% tax rate, DMPHF beats the other by $407.80/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of DMPHF + SPHD for your $10,000?

DMPHF: 50%SPHD: 50%
100% SPHD50/50100% DMPHF
Portfolio after 10yr
$26.6K
Annual income
$811.20/yr
Blended yield
3.04%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

DMPHF buys
0
SPHD buys
0
No recent congressional trades found for DMPHF or SPHD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricDMPHFSPHD
Forward yield2.17%4.33%
Annual dividend / share$1.05$2.14
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR14%0%
Portfolio after 10y$26.8K$26.5K
Annual income after 10y$1,051.08$571.32
Total dividends collected$5.6K$5.1K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: DMPHF vs SPHD ($10,000, DRIP)

YearDMPHF PortfolioDMPHF Income/yrSPHD PortfolioSPHD Income/yrGap
1$10,947$247.34$11,133$432.85$186.00SPHD
2$12,002$288.49$12,363$450.36$361.00SPHD
3$13,179$336.98$13,695$467.39$516.00SPHD
4$14,496$394.23$15,138$483.90$642.00SPHD
5$15,973$461.99$16,697$499.88$724.00SPHD
6$17,633$542.36$18,382$515.31$749.00SPHD
7$19,505$637.91$20,198$530.17$693.00SPHD
8$21,623$751.80$22,157$544.46$534.00SPHD
9$24,024$887.92$24,266$558.18$242.00SPHD
10← crossover$26,757$1,051.08$26,536$571.32+$221.00DMPHF

DMPHF vs SPHD: Complete Analysis 2026

DMPHFStock

Dermapharm Holding SE, together with its subsidiaries, engages in the off-patent branded pharmaceuticals business in Germany and internationally. It operates through three segments: Branded Pharmaceuticals and Other Healthcare Products, Parallel Import Business, and Herbal Extracts. The company develops, manufactures, licenses, markets, and sells branded generics, over-the-counter drugs, non-prescription natural remedies, and other healthcare products. It also offers healthcare products in the areas of vitamins, minerals, food supplements, dermatology, allergology, pain and inflammation treatment, cardiovascular support, gynecology, and urology primarily under the Dekristol, Dekristolvit, Allergovit, and Tromcardin brands. In addition, the company provides medical devices under the bite away and Herpotherm names; Momekort, a nasal spray used to treat allergy symptoms; and Azedil, a nasal spray or eye drop. Further, it imports originator pharmaceuticals under the axicorp brand; and offers herbal extracts and natural active ingredients for phytopharmaceuticals, nutraceuticals, and cosmetics. It serves pharmaceutical wholesalers, pharmacies, hospitals, and health food stores. The company was founded in 1991 and is headquartered in Grünwald, Germany. Dermapharm Holding SE is a subsidiary of Themis Beteiligungs-Aktiengesellschaft.

Full DMPHF Calculator →

SPHDETF

The Invesco S&P 500 High Dividend Low Volatility ETF (Fund) is based on the S&P 500 Low Volatility High Dividend Index (Index). The Fund will invest at least 90% of its total assets in common stocks that comprise the Index. Standard & Poor's compiles, maintains and calculates the Index, which is composed of 50 securities traded on the S&P 500 Index that historically have provided high dividend yields and low volatility. The Fund and the Index are rebalanced and reconstituted semi-annually, in January and July.

Full SPHD Calculator →
📬

Get this DMPHF vs SPHD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

DMPHF vs SCHDDMPHF vs JEPIDMPHF vs ODMPHF vs KODMPHF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.